The Effect of Omega-3 Fatty Acids (Omacor) on the Response Rate to Antiviral Therapy in Patients With Chronic Hepatitis C Infection.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 11 Jan 2017
At a glance
- Drugs Interferon; Omega-3-acid ethyl esters
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Aug 2012 Actual end date (1 Aug 2012) added as reported by ClincialTrials.gov.
- 08 Jul 2011 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 13 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.